You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Augmented Reality Training Tools with Realistic Animations and Voice Navigation on Tablet and AR Headset for Combat Casualty Care

    SBC: SHARP VISION SOFTWARE LLC            Topic: DHP163002

    Development of Augmented Reality (AR) training tools for combat casualty care with realistic animations and voice navigation capability on tablets and AR headset is proposed to enhance the tools that have already been developed during the Phase II effort on fasciotomy, cricothyroidotomy, and lateral canthotomy. Such enhancements are made possible by the recent advancement in both hardware and soft ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  2. Far-Forward Austere Sterilizer (FAST)

    SBC: LYNNTECH INC.            Topic: DHA213006

    Sterilization of medical and surgical tools is a critical step in minimizing the risk of infection to combat casualties during far-forward medical interventions. However, there are significant challenges to providing sterile equipment in austere environments where power is limited and ability to transport equipment and deliver supplies is constrained. The complexity of modern surgical tools, such ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  3. Ingestible Capsule for Vital Sign Monitoring

    SBC: NANOHMICS INC            Topic: A20BT021

    Hostile combat environments with high casualty rates leave forward medical providers isolated and over-tasked with limited capacity for resupply. To address these limitations, innovative medical technologies that provide continuous assessment of the physiological status of injured military servicemen are in high demand. Specifically, the ability for real-time, vital sign monitoring and reporting s ...

    STTR Phase II 2023 Department of DefenseDefense Health Agency
  4. Bougie-Integrated Endotracheal Intubation Stylet

    SBC: Olifant Medical, Inc.            Topic: DHA213004

    It is well established that difficulty and multiple attempts at endotracheal intubation (ETI) during emergency circumstances result in up to a 4-fold increase in complications, including cardiac arrest. In the tactical combat casualty care (TCCC) environment, ETI encompasses the majority of combat prehospital airway securement. Unfortunately, ETI is one of the most common incorrectly performed lif ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  5. Revisiting the Nasopharyngeal Airway (NPA): The Next-Level NPA

    SBC: Olifant Medical, Inc.            Topic: DHA213003

    Airway compromise continues to account for approximately 1 in 10 preventable battlefield deaths. Combat medics often provide care in no or low-light conditions, surrounded by the chaos of combat, and with the limited dexterity that accompanies bulky body armor, gloves, and heavy equipment. Far-forward medical care is also limited by available resources, which are often only what a combat medic can ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  6. StepWise Virtual Tutor for Math Word Problems Using SRSD

    SBC: QUERIUM CORPORATION            Topic: 91990023R0016

    Not available

    SBIR Phase II 2023 Department of EducationInstitute of Education Sciences
  7. Point of Care Test for Disease Severity and Risk Stratification

    SBC: LYNNTECH INC.            Topic: DHA172008

    The CBC Analyzer Phase II Enhancement effort will be to optimize, test, and package the prototype. The advancement of the microfluidic cartridge performance will incorporate cell separation techniques within the current microfluidic cartridge design. This will be based on Lynntech’s preliminary work with blood separation, where a novel blood component separator was developed which uses a centerl ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  8. Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire

    SBC: Altrazeal LIfe Sciences Inc.            Topic: A20137

    Sepsis is the greatest danger after hemorrhage in both civilian and combat-related injuries with mortality rates ranging between 19.5 - 23%. Early intervention with appropriate antibiotics, hemodynamic optimization, and supportive care are particularly vital in preventing trauma related sepsis. Treatments to prevent trauma sepsis may be confounded by the uncontrolled bleeding which often attends s ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  9. Multiplexed, High-throughput Functional Assay to Evaluate Bactericidal Activity of Antibodies Against Shigella

    SBC: LYNNTECH INC.            Topic: DHA202002

    Shigella infection is one of most common medical problems for deployed military personnel. Shigella infection causes acute diarrheal as well as chronic functional bowel disorders and reactive arthritis, and the infection keeps our service members out of fight, threatening unit readiness. Therefore, the need of prevention of Shigella infection has become a high priority for US Service Members. Both ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  10. Molecular Rebar Design's Discrete Multiwalled Carbon Nanotube HIV Therapy Technology

    SBC: MOLECULAR REBAR DESIGN LLC            Topic: DHA211010

    DNA encoded monoclonal antibodies (dmAbs) have been shown to be an effective treatment against a range of infectious diseases including Ebola, Zika, and HIV.  However, delivering plasmid DNA into cells and tissues safely and effectively is a challenge that has so far prevented widespread adoption of dmAbs as a therapeutic.  In Phase I of this project, Molecular Rebar Design (MRD) introduced a so ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government